“Comparative Efficacy of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Treatment Response in Atopic Dermatitis at Varying Treatment Continuance Rates”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s519. Accessed May 30, 2025. https://skin.dermsquared.com/skin/article/view/3158.